6.710 8.58%

Research Hotspot

Click Each Keyword to Figure Out More

Lkb1 Surgical Database Kras-mutant Group Between Lymph Positron-emission Consideration Tracheoesophageal Potential Checkmate Sarcomatoid Future Invasion Imaging Consensus Profiling Influence Evaluation Ddr Serum Alk-positive Palliation Initial Pattern Swog Limited-stage System Possible Convert Consortium European Characterization Autoimmune Chemoradiation Loss Algorithm Standard Skipping Nonsquamous Implication Real-world Adjuvant Different Inflammation Statement Preliminary Common Flaura Program Diversity Micronodules Descriptor Cranial Joint Pathological High Surveillance Landscape Progression Mutational Identified Level Nrg1 Alk+ Enhances Pollution Assessment Steering Minimal Site Subtype Mass Trametinib Predictor Palliative Family Previous Nivolumab-induced Egfr-mutant Disparity Intrapulmonary Postoperative Health Radiologic Dehydrogenase Virus Prevalence Predictive Pd-1 Cycle Heterogeneity Fibroblast Intracranial Exceptional Related C797s Correlation Marker No Proposal Margin Myofibroblastic Alex Matter Recurrent Double Biomarkers Panel Confers Sensitive Utility Opacity Gut Smoking Signature Iraes Irradiation Mortality Subtypes Cholangitis Arterial Region Optimal Critical Resectable Germline Eml4-alk Identifies Atypical Pemetrexed Doe Complication Hitherto Lymphoma Make Era Class Kras Resected Tki Airway Fulminant Effectiveness Update Therapeutic Navigate Recommendation Predicts Extended Experience Against Prior Oncogenic Epidermal Assay Room Histologic Mediated Drug Undergoing Three Alcohol Standardization Encephalitis Cetuximab Nuance Year Distinct Development Their Organ-specific Target Open-label Frameshift Dose Strategy Part-solid Ncslc Onset Rare Oligometastatic Poor Ramucirumab Low Cessation Final Cooperative Brief Newly Amplification Failure Pneumonia Erk Incidence Differentiate Second-line Targeting Ground-glass Double-fusion Docetaxel Age Ablative Immune-related Microbiome Paclitaxel North Complex Lorlatinib Clinically Project Conventional Determinant Biopsy Placebo Eosinophilic Poziotinib Use

Journal of Thoracic Oncology - Journal Impact

The Journal Impact 2019-2020 of Journal of Thoracic Oncology is 6.710, which is just updated in 2020. Compared with historical Journal Impact data, the Factor 2019 of Journal of Thoracic Oncology grew by 8.58% . The Journal Impact Quartile of Journal of Thoracic Oncology is Q1. The Journal Impact of an academic journal is a scientometric factor that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a factor for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Journal of Thoracic Oncology.


Journal of Thoracic Oncology Real-Time Journal Impact/Jouranl Factor Prediction & Tracking, 2020 2019 2018 2017 2016 2015 Journal Impact | Factor Trend & History - Academic Accelerator


Journal of Thoracic Oncology - Journal Impact Prediction System

Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future factor and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven factor without secret algorithms, hidden factors, or systematic delay.

Journal of Thoracic Oncology Journal Impact Prediction System - Factor and Trend
  • Article Volume 2017 321
  • Article Volume 2016 528
  • Article Volume 2015 326
  • ISSN
  • 15561380, 15560864
  • Open Access
  • Publisher
  • Elsevier Inc.
  • Country/Region
  • United States
  • History
  • Categories
  • Medicine (miscellaneous) (Q1), Oncology (Q1), Pulmonary and Respiratory Medicine (Q1)

Journal of Thoracic Oncology - ISSN

The ISSN of Journal of Thoracic Oncology is 15561380, 15560864. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Journal of Thoracic Oncology - ISSN

Journal of Thoracic Oncology - Subscription (non-OA) Journal

Journal of Thoracic Oncology is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Journal of Thoracic Oncology - Open Access

Journal of Thoracic Oncology - Publisher

Journal of Thoracic Oncology is published by Elsevier Inc., which is located in the United States. The Publication History of Journal of Thoracic Oncology covers 2006-ongoing.

Journal of Thoracic Oncology - Publisher

Journal of Thoracic Oncology - Categories

Journal of Thoracic Oncology is a peer-reviewed scientific journal. The scope of Journal of Thoracic Oncology covers Medicine (miscellaneous) (Q1), Oncology (Q1), Pulmonary and Respiratory Medicine (Q1).

Journal of Thoracic Oncology - Categories

Journal of Thoracic Oncology - Journal Factors

It is impossible to get a true picture of impact using a single factor alone, so a basket of factors is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Factors including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Journal of Thoracic Oncology.

Journal of Thoracic Oncology - Journal Metrics

Journal Ranking